Hypoxia-inducible factors (HIFs) belong to a broader group of transcription factors comprising the basic helix-loop-helix-PAS family (per/aryl-hydrocarbon-receptor nuclear translocator (ARNT)/ Sim). 1 HIFs consist of a labile ␣ subunit (HIF-1␣, HIF-2␣, or HIF-3␣) and a common stables ␤ (ARNT) subunit that heterodimerize to form a functional transcriptional complex. The heterodimer can translocate to the nucleus and transactivate a myriad of target genes (e.g., erythropoietin) in conjunction with a number of co-factors. Direct transcriptional activation of hypoxia-inducible genes occurs by binding of HIF to hypoxiaresponse elements, consensus sequences present in the regulatory regions.
The primary mechanism of regulation of HIF activity is through oxygendependent proteasomal degradation of the HIF-␣ subunit ( Figure 1 ). 2, 3 Under normoxic conditions, members of the prolyl hydroxylase domain (PHD) family of proteins (herein called PHDs) hydroxylate HIF-␣ at one or both conserved prolyl residues on HIF-␣ (proline 402 and 564 in HIF-1␣). All HIF PHDs (PHD1, PHD2, and PHD3) require oxygen, Fe 2ϩ , and 2-oxoglutarate for their activity (Figure 1 ). Hydroxylated HIF-␣ is then recognized by the VHL E3 ubiquitin ligase (composed of the von Hippel-Lindau tumor suppressor protein [pVHL] , Cullin2, elongin C, and Rbx1), which polyubiquitinates HIF-␣ and marks it for destruction by the 26S proteasome. At low-oxygen tension or in the absence of pVHL (e.g., after mutational loss of VHL in clear cell renal cancer), HIF-␣ escapes degradation. HIF-␣ then heterodimerizes with HIF-␤ (ARNT) and binds the transcriptional co-activator, CBP/p300, to form the active transcriptional complex that translocates to the nucleus and mediates transactivation of hypoxia-response element-containing genes. 4 -7 Because the intracellular partial pressure of oxygen is at most times below the K M (of PHDs) for oxygen, oxygen availability is a determinant of PHD activity. 8, 9 In addition to oxygen, PHD activity can be modulated by a number of metabolic intermediates or PHD co-factors, including reactive oxygen species, ascorbate, succinate, fumarate, and nitric oxide (Figure 2) . 10 Under hypoxic conditions, the stability of PHD1 and PHD3 is regulated by the E3 ligases Siah1a/2 (Figure 2 ). 11 HIF-␣ is also regulated at various sites in the pathways described in Figures 1 and 2. Acetylation of HIF-1␣ by an acetyltransferase, ARD1, has been shown to enhance the interaction of HIF-1␣ with pVHL and is required for its degradation. 12 Furthermore, researchers recently uncovered that HIF-␣ is further regulated under hypoxic conditions by conjugation to small ubiquitin-like modifiers (SUMO) that regulate its transcriptional activity. [13] [14] [15] Hypoxia induces SUMOylation of HIF-1␣, which promotes its binding to VHL protein, through a proline hydroxylation-independent mechanism, ultimately leading to its degradation. Furthermore, mice lacking SENP1 (a Sentrin/ SUMO-specific protease 1) die from anemia secondary to erythropoietin deficiency because of a defect in deSUMOylation resulting in HIF's being targeted for degradation under hypoxic conditions (see Figure 1 ). 16 The role of sumoylation in HIF regulation is still under intense investigation and alternative mechanisms have been proposed. A number of studies have shown that HIF-␣ is regulated through mechanisms independent of oxygen content or independent of VHL. For instance, Mekhail et al. 17, 18 reported that a decrease in environmental pH (which occurs early with tissue hypoxia before HIF induction by inactivation of PHD activity) results in sequestration of VHL in the nucleolus neutralizing its (VHL) ability to facilitate degradation of HIF.
In addition to hydroxylation at prolyl residues, HIF hydroxylation occurs at a conserved asparagine residue by factorinhibiting HIF-1 (FIH-1), which blocks the recruitment of transcriptional co-activators p300 and CBP and limits HIF transactivation. 19 -27 FIH-1 hydroxylates HIF under normoxia and mild hypoxia but not under pronounced hypoxia, presumably to suppress the activity of HIF-␣ proteins that escape degradation under moderate hypoxia. 28, 29 Taken as a whole, the complex regulatory pathways that govern HIF-␣ activity support the notion that inappropriate HIF activation can have drastic consequences on cell growth, differentiation, and metabolism ( Figure 3 ; see next section).
HIF-␣ SUBUNITS
Both HIF-1␣ and HIF-2␣, the most studied members of the family, exhibit similar functional domain structures, containing DNA binding and dimerization domains at their N termini and transactivation domains at their C termini. 23,30,31 HIF-3␣, the least well understood member of the family, contains no transactivation domain and demonstrates dominant negative regulation of HIF-mediated control of gene expression. 32 HIF-1␣ and HIF-2␣ regulate either unique or identical target genes. [33] [34] [35] [36] [37] [38] [39] For example, HIF-1␣ specifically regulates glycolytic genes (including phosphoglycerate kinase and lactate dehydrogenase A), 33,39,40 as well as carbonic hydrase-9 34 and BNIP3, 36 whereas HIF-2␣ exclusively regulates the Pou transcription factor Oct-4, cyclin D1, and TGF-␣. 36,37,41 Other hypoxia-inducible genes, such as vascular endothelial growth factor (VEGF), facilitated glucose transporter-1, adipose differentiation-related protein, adrenomedullin, and N-myc downstream regulated 1, are regulated by both HIF-1␣ and HIF-2␣. 33, 36, 42 These findings are congruent with functional studies indicating that HIF-1␣ and HIF-2␣ exhibit distinct roles during development. 36, [43] [44] [45] [46] [47] It is the N-terminal transactivation domain that confers target gene specificity of HIF-1␣ and HIF-2␣. 48 These data have to be put into context of cell specificity because embryonic stem cells (and perhaps other cell types) seem to express a HIF-2␣-specific co-repressor that inhibits transcription of HIF-2␣ targets. 42 In addition to their differential transactivating properties, both HIF-1␣ and HIF-2␣ have different patterns of expression in each organ and cell type within that organ. Initially, HIF-2␣ was named endothelial PAS protein 1 because its expression was thought to be restricted to endothelial cells in mice. 22 Now it is apparent that HIF-2␣ is more widely expressed than pre- Figure 1 . Regulation of HIF. Under normoxia, HIF-␣ is hydroxylated in the oxygendependent destruction domain (Pro402 or 564 of HIF-1␣) and at an asparagine residue in the C terminal transactivation domain (Asn803 of HIF-1␣). Prolyl hydroxylation by PHD is required for binding to the pVHL-E3-ubiquitin ligase complex, whereas asparaginyl hydroxylation prevents the interaction of HIF-␣ with CBP/p300 transcriptional co-activator (bottom right). Upon binding to the E3-ligase complex, HIF-␣ is polyubiquitinated and then degraded by the proteasome. Acetylation of HIF-␣ by ARD1 enhances binding to pVHL and subsequent ubiquitination. During hypoxia when prolyl-hydroxylases are inactive, HIF-␣ is stabilized and translocates to the nucleus, where it is SUMOylated by SUMO conjugases. Failure to deSUMOylate HIF-␣ (e.g., absence of SENP1) targets HIF-␣ for VHL/proteasome-dependent degradation by providing an alternate signal (prolyl hydroxylation-independent) for pVHL binding. DeSUMOylated HIF-␣ escapes degradation, heterodimerizes with HIF-1␤, binds to the hypoxia response elements (consensus binding site), and increases transcription of HIF target genes such as VEGF. Oxygen-dependent asparagine hydroxylation of HIF-␣ by factor-inhibiting HIF-1 (FIH-1) blocks recruitment of the CBP/p300 co-factor to the HIF transcriptional complex. This diagram depicts the regulatory pathway for HIF-1␣, and it is generally applicable to HIF-2␣; however, whether acetylation and SUMOylation/deSUMOylation also affect HIF-2␣ is not known.
viously thought. 49, 50 For instance, in hypoxic kidneys, HIF-2␣ is expressed in the erythropoietin-producing interstitial fibroblasts and peritubular endothelial cells, whereas HIF-1␣ is expressed in the tubular epithelial cells. 51 The functional difference between these HIF-␣ isoforms is particularly apparent in the pathogenesis of VHL renal tumorigenesis, in which HIF-1␣ inhibits tumor growth whereas HIF-2␣ promotes tumor growth in VHL-deficient renal cell carcinoma models. 36, 43, 44 The differential tumorigenic potential of HIF-1␣ and HIF-2␣ can be attributed to a number of mechanisms, including contrasting effects on c-Myc activity or differential induction of growth-promoting pathways. 36,41,52,53
METABOLIC CONSEQUENCES OF HYPOXIA
When oxygen supply is inadequate, many cells shift from aerobic to anaerobic metabolism, and glycolysis becomes the primary mode of energy production. 54,55 Glycolysis, however, is an inefficient method of generating energy, producing a net of only 2 mol of adenosine triphosphate (ATP)/mol glucose as compared to approximately 36 mol ATP/ mol glucose during aerobic respiration. 56 Acute hypoxia (Ͻ1 h) induces alterations in protein phosphorylation as well as other post-translational modifications, whereas chronic hypoxia generally leads to changes in gene expression patterns. Stabilization of HIF and transcriptional activation of hypoxia-inducible genes is a central mechanism of adaptation to hypoxia. 57,58 Notwithstanding, a variety of HIF-independent pathways promote ATP conservation by limiting energy-consuming processes such as cell division, ribosome biogenesis, mRNA translation, and ion channel activity. Although other transcription factors, such as AP-1, EGR-1, NF-B, and NF-IL-6, can mediate hypoxia-inducible expression of specific genes in specific cell types, HIF-1 seems to be unique with respect to its function as a global regulator of oxygen-sensitive homeostasis. A discussion of HIF-independent pathways is beyond the scope of this review and is nicely described by Simon et al. 59 
HIF TARGET GENES IN OXYGEN HOMEOSTASIS
Anemia is a common complication of chronic kidney disease (CKD) and arises from an absolute deficiency of erythropoietin (EPO), an essential hormone that stimulates red blood cell production. EPO was the first hypoxia-inducible gene to be identified. 60 Peritubular fibroblasts within the renal cortex greatly increase EPO transcription when they sense decreases in oxygen tension as a result of anemia, ischemia, or any other cause of decreased oxygen availability. Affinity purification of a nuclear factor that upregulated EPO transcription seven-fold by hypoxia-dependent binding within the 3Ј flanking enhancer region of the EPO gene led to the discovery of HIF-1␣ in liver cells. 60,61 Gene-targeting experiments later revealed that EPO expression is primarily regulated by HIF-2␣, and its expression is primarily restricted to the prenatal liver and the kidney after birth. 62 Interestingly, a homozygous mutation in the VHL gene (Arg200Trp) can give rise to Chuvash polycythemia, an autosomal recessive disorder in which erythroid progenitors both are hyperresponsive to EPO and produce EPO in a dysregulated manner. 63 Over the years, it Figure 2 . Oxygen-dependent and oxygen-independent regulation of HIF-prolyl hydroxylases. All HIF PHDs require oxygen, Fe 2ϩ , and 2-oxoglutarate for prolyl hydroxylation activity. Nitric oxide (NO), reactive oxygen species (ROS), the Krebs cycle metabolites succinate and fumarate, cobalt chloride (CoCl 2 ), and Fe chelators (not shown) such as desferroxamine inhibit the PHD family of HIF prolyl hydroxylases in the presence of oxygen. A number of HIF prolyl hydroxylase inhibitors are at various stages of preclinical and clinical trials. Although PHD2 is the primary HIF hydroxylating enzyme in mammals, PHD1 and PHD3 can contribute to HIF regulation in certain cell types and under specific conditions. Paradoxically, NO inhibits HIF-␣ induction under hypoxia. 128 Growth factor signaling by nerve growth factor (NGF) in sympathetic neurons has been shown to inhibit PHD expression. 129, 130 Under hypoxia, PHD1, and PHD3 are targeted for proteasomal destruction by the E3 ligases Siah1/2. HIF-1␣ is expressed in most renal epithelial cells, whereas HIF-2␣ is mainly found in endothelial cells and renal interstitial fibroblast-like cells in response to hypoxia, ROS, NO, NGF, and Toll-like receptor 4 (TLR4) activation or NF-B signaling in myeloid cells (not shown). 131 BRIEF REVIEW www.jasn.org has been appreciated that HIFs play a much broader role in the cellular homeostatic response to hypoxia. 57 The list of HIF-regulated genes has grown to more than 100, with many target genes having direct relevance to the adaptation or maladaptation of the kidney during acute kidney injury (AKI) and chronic kidney disease (CKD). 64, 65 HIFs play a fundamental role in the switch to anaerobic respiration during oxygen starvation through enhanced expression of glucose transporters, that enhance glucose uptake, and glycolytic enzymes. 1, 58 Other notable HIF target genes include VEGF, heme oxygenase 1, tissue inhibitor of metalloproteinase, connective tissue growth factor, stromal-derived growth factor 1, and nitric oxide. 66 HIF-␣ also interacts with a number of proteins. Some regulate HIF-␣ stability. Others regulate HIF transcriptional activity or are themselves regulated by HIF-␣. Noncanonical HIF signaling occurs through interaction with cellular proteins that modulate key cell biologic processes. For instance, HIF-1␣ synergizes with the Notch pathway to control cell fate determination under hypoxic conditions. 67 HIF-1␣ binds the intracellular domain of Notch after activation and cleavage of full-length Notch. The HIF-Notch intracellular domain complex then translocates to the nucleus, where it promotes Notch-dependent transcription. HIF-1␣ also represses c-Myc activity to inhibit mitochondrial biogenesis and cellular oxygen consumption. 68 Moreover, contrasting effects on c-Myc activity by HIF-1␣ (antagonizes) and HIF-2␣ (enhances) can inhibit or promote cell-cycle progression, respectively, under hypoxic conditions. 53,69 Thus, HIF-␣ plays a profound role in determining cell behavior during hypoxia. A comprehensive review by Wenger et al. 70 nicely discusses HIF target genes and HIF-interacting proteins.
OXYGEN DELIVERY TO THE KIDNEY
Whereas hypoxia is a term used to describe oxygen insufficiency, ischemia is 68, 136 The cellular context and/or timing of HIF-␣ induction is believed to determine how the numerous signaling pathways described contribute to renal recovery, to development, and to the progression of chronic injury in the kidney. A critical role for HIF-1␣ in myeloid cell inflammation is highlighted by the following: (1) HIF-1␣ deficiency in myeloid cells results in reduced glycolytic capacity and in impairment of cell aggregation, motility, invasiveness, and bacterial killing 112 ; (2) HIF-1␣ induction in macrophages promotes the production of inflammatory cytokines, including TNF-␣ and IL-1; and (3) deletion of HIF-1␣ is protective against LPS-induced sepsis in mice. 131 an absolute or relative shortage of blood supply to an organ. Hypoxia can result when oxygen demand exceeds supply, which occurs during ischemia. 38 Paradoxically, the renal medulla has the lowest physiologic PO 2 compared with any other organ despite the fact that the kidney receives the largest fraction of the cardiac output. [71] [72] [73] Medullary hypoxia is an inevitable consequence of the unique architecture of the medullary vasculature that serves a countercurrent isolation function that prevents the medullary solute gradient from being dissipated and hence allows for urinary concentrating ability. 72, 74, 75 The antiparallel arrangement of blood vessels allows diffusional shunting of oxygen between descending arterial vasa recta and ascending venous vasa recta (countercurrent exchange). As a consequence, the oxygen tension in the renal outer medulla remains between 10 and 20 mmHg with even lower oxygen tensions in the inner medulla, whereas the cortex benefits from an oxygen tension between 30 and 50 mmHg. 71, 72 At the same time, tubular cells within the S3 segment of the proximal tubule have a higher oxygen demand as a result of abundance of active Na/K-ATPases and other ATP-dependent metabolic processes. The medullary thick ascending limb of Henle's loop also has a high energy demand, but, in contrast to the proximal tubule, this nephron segment can convert from oxidative to glycolytic metabolism and hence can withstand hypoxia better than the adjacent proximal straight tubules in the outer medulla. 76 -78 Inhibition of active transport along the loop of Henle with furosemide can increase medullary PO 2 . 79 With compromised blood flow to the outer medulla, which occurs during AKI, hypoxic injury, particularly to the S3 segment, can occur when oxygen demand exceeds supply. 38 
RENAL DEVELOPMENT
Kidney development is a period of rapid cell growth with assembly of the vasculature whereby mismatch in oxygen supply and demand can result in regions of relative hypoxia and HIF activation. HIF-1␣ is expressed in nearly all tissues, whereas HIF-2␣ is more restricted in its expression pattern, observed in the endothelium, kidney, liver, and brain. 22 Within the developing kidney, HIF-1␣ is expressed weakly in the outer cortex and strongly in some tubular and collecting duct epithelial cells. HIF-2␣ was localized to glomeruli with dense staining in the nuclei of podocytes and microvascular endothelial cells. Mice genetically deficient in HIF-1␣ die at midgestation (embryonic day 9.5 [E9.5]) from vascular and neural tube defects. 80, 81 Stem cells derived from HIF-1␣ Ϫ/Ϫ mice fail to produce VEGF in response to hypoxia, and embryos display abnormalities in yolk sac vasculature. Conversely, the phenotypes of mice carrying germline deletion of HIF-2␣ varies greatly depending on the genetic background. 82 For instance, Tian et al. 22 observed embryonic lethality at midgestation as a result of bradycardia from defective catecholamine synthesis, whereas Peng et al. 83 observed embryonic lethality at E9.5 to E13.5 without any evidence of heart rate or catecholamine differences. A third group, Compernolle et al., 84 found that HIF-2␣-deficient mice died between E13.5 or as late as 3 d after birth as a result of respiratory distress syndrome caused by poor differentiation of surfactant-producing type 2 pneumocytes. Surprisingly, HIF-2␣ null embryos showed no defects in renal vascular development or nephrogenesis despite no compensatory upregulation of HIF-1␣ or -3␣. Not surprising, HIF-1␤ null embryos did not survive past E10.5 as a result of defects in angiogenesis in the yolk sac and brachial arches. 85 Although knockout of HIF genes in mice results in embryonic lethality, it has been possible to draw some conclusions about their roles in renal development using fetal organ culture. When E13.5 metanephroi were cultured in mild hypoxia (5% oxygen), both HIF-2␣ heterozygous and null tissue had equivalent doubling of VEGF mRNA. Furthermore, there no morphologic or histologic differences were observed between HIF-2␣ knockout or heterozygous metanephroi transplanted into the anterior eye chambers of adult hosts. 86 Taken together, these data indicate that there is likely no identified role for HIF-2␣ in renal vascular or glomerular development in mice.
As an important downstream effector of HIF-␣, VEGF is a critical mediator of vasculogenesis. Heterozygous and homozygous null VEGF-A mice die with major vascular defects at 11.5 and 9.5 d after coitus, respectively. 87, 88 A specific role for VEGF in glomerular development was uncovered by injecting VEGFneutralizing antibodies into newborns, when the kidneys are still developing. This resulted in fewer nephrons and many abnormal glomeruli lacking glomerular tufts. 89 In addition, glomerularselective deletion or overexpression of VEGF-A in mice leads to severe and early glomerular disease in mice. Podocytespecific heterozygosity for VEGF-A resulted in renal disease by 2.5 wk of age, characterized by proteinuria and endotheliosis. 90 Markers of differentiated mesangial cells, such as vascular smooth muscle actin-␣, are completely absent in the glomeruli of these mice. In contrast, podocyte-specific overexpression of the VEGF-164 isoform led to a striking collapsing glomerulopathy. The studies by Eremina and Quaggin 91 demonstrated that tight regulation of VEGF-A signaling is critical for establishment and maintenance of the glomerular filtration barrier and strongly support a pivotal role for VEGF-A in renal disease. The vital role of VEGF produced by podocytes for the maintenance of healthy glomerular endothelial cells and a proper filtration barrier is further underscored by the development of thrombotic microangiopathy in humans treated with antibody targeting VEGF. 92 In conclusion, VEGF, whose expression is regulated by HIF, seems to have a pivotal function in development and preservation of functional glomeruli in mice and perhaps in humans.
The syndrome can range from overt tubular necrosis to mild perturbations in GFR without significant pathologic changes (prerenal azotemia). Unfortunately, AKI continues to be a major cause of morbidity and mortality worldwide and is increasingly considered as a leading cause of ESRD. Treatment for AKI is lacking. 94 Ischemic injury, often complicated by sepsis, is the leading cause of AKI, while nephrotoxins and obstruction are other common causes. 95 ATP depletion is an important effector of tubular cell injury during prolonged hypoxia. 96 Cytoskeletal disruption leads to loss of brush border, breakdown of cell junctions, and mislocalization of integrins and sodium-potassium ATPases from the basal surface to the apical surface. Brush border membranes and cells slough and may obstruct tubules downstream. In addition, surges in free intracellular calcium owing to failure of active transport mechanisms activate harmful proteases and phospholipases, which, with reperfusion, cause oxidant injury to tubular cells. 97 Peritubular capillary endothelial cells suffer a similar fate as tubular cells, especially in the outer medulla. A pathologic feature of ischemic AKI is a shift in the balance of vasoactive substances toward vasoconstrictors such as endothelin, resulting in vasoconstriction, congestion, and further hypoperfusion. The ensuing inflammatory milieu, contributed to by a flood of proinflammatory and chemotactic cytokines generated by ischemic tubular cells, incites upregulation of adhesion molecules on endothelial cells, which, in turn, initiate leukocyte adhesion and infiltration. In addition, infiltrating leukocytes obstruct the microcirculation and themselves release cytotoxic cytokines, reactive oxygen species, and proteolytic enzymes, which damage the tubular cells further. 97 In vitro, HIF-1␣ and/or HIF-2␣ is expressed in investigated cell lines exposed to hypoxic conditions. For instance, halfmaximal induction of HIF-␣ occurs when Hela cells (a transformed cervical cancer cell line) are cultured at 1.5 to 2.0% oxygen, which corresponds to an oxygen tension of 10 to 15 mmHg, and this approximately equals values measured in the renal medulla of rats breathing room air. 98 Ubiquitous expression of a reporter protein consisting of the luciferase gene fused to HIF-1␣ (to the oxygen-dependent degradation domain specifically) in mice revealed that the kidneys of mice breathing room air contain hypoxic zones where HIF is activated. 73 The detailed expression pattern of HIF-1␣ and HIF-2␣ in the kidneys of rats exposed to various hypoxic stimuli (0.1% carbon monoxide, cobalt chloride, and renal ischemia) was meticulously described by Rosenberger et al. 51 HIF-1␣ was observed in some glomeruli, tubular cells (collecting duct, connecting tubules, and proximal segments), and interstitial cells. HIF-2␣ staining was not observed in tubular cells but was noted in glomeruli and peritubular endothelial cells (vasa recta of the outer stripe and periglomerular arterioles) and peritubular fibroblasts. Notably, there was variability in HIF-␣ expression with respect to intensity and cell specificity between experimental models of hypoxia (carbon monoxide versus cobalt chloride versus ischemia). 51 In the glycerol-induced rhabdomyolysis model of AKI, HIF induction correlated with cellular hypoxia, and expression of both HIF-1␣ and HIF-2␣ was similar to that observed in ischemic models of AKI. 99 The selective expression of HIF-1␣ and HIF-2␣ in distinct cell populations within the hypoxic kidney suggests largely divergent physiologic roles.
ISCHEMIC PRECONDITIONING
Exposing the kidney to an ischemic or toxic insult can protect it against subsequent exposure to ischemia. 100 In essence, it is a strategy aimed at "training" the kidney to tolerate injury. This concept, referred to as ischemic preconditioning, is supported by nearly a century of experimental work on the kidney and other organs. Considerable effort has gone into uncovering mechanisms involved in preconditioning at the cellular and molecular levels. Some of the possible explanations for preconditioning include (1) reduced differentiation state of cells, (2) reduced phosphorylation of mitogen-activated protein kinases and reduced susceptibility to apoptosis, and (3) decreased leukocyte-endothelial interactions and reduced vascular congestion. Because many adaptive processes to hypoxia are mediated by HIF, preemptive activation of HIF-inducible genes was hypothesized to be a viable strategy to prevent subsequent ischemic/toxic injury. 101, 102 There is now growing evidence to support this notion from a variety of experimental model systems. Pretreatment with the prolyl-hydroxylase inhibitor FG-4487 before clamping the renal artery in uninephrectomized rats leads to appropriate activation of HIF-1␣ and HIF-2␣, as described previously by Eckardt and colleagues. 103, 104 FG-4487 pretreatment leads to significantly reduced serum creatinine increases and ATN scores after ischemia. Preconditioning with carbon monoxide, a strong inducer of HIF in the kidney, has similar benefits. 51, 104 These studies, however, do not rule out HIF-independent or off-target effects of prolyl-hydroxylase inhibitors. 105 Although homozygous HIF-1␣-and HIF-2␣-deficient mice die in utero, mice heterozygously deficient for HIF-␣ with reduced HIF-␣ expression can serve as excellent genetic tools. 82 Recently, Cai et al. 106 demonstrated that HIF-1␣ heterozygous mice fail to show cardiac protection in the acute phase of ischemic preconditioning compared with wildtype controls. In keeping with this, Maxwell and colleagues 107 revealed that both HIF-1␣ ϩ/Ϫ and HIF-2␣ ϩ/Ϫ mice suffer substantially more injury after ischemia/ reperfusion to kidneys when compared with littermate controls. Using a similar genetic approach, Kojima et al. 108 showed that mice with defective HIF-2␣ expression (50% less under ischemic conditions) are more susceptible to renal ischemia/reperfusion injury, as indicated by elevated blood urea nitrogen levels and semiquantitative histologic analysis. These studies propose protective roles for HIFs in ischemia/reperfusion injury to the kidneys.
It is interesting that both HIF-1␣ and HIF-2␣ deficiency exacerbates ischemic injury to a similar extent given that (1) both HIF-␣ isoforms are expressed in distinct cell types, 51 (2) both HIF-␣ isoforms have separate and common transcriptional targets, 36,109 and (3) HIF-␣ isoforms have contrasting effects on c-Myc (Figure 3) . 53, 68, 110, 111 In addition, the direct role of either HIF-␣ isoform in ischemic preconditioning has not been addressed in the kidney, although HIF-1␣ deficiency abrogates the protection afforded by preconditioning in lung and cardiac ischemia/reperfusion models. 84, 106 Furthermore, HIF-1␣-null myeloid cells have defective inflammatory responses as a result of defective glycolytic capability. 112 It is plausible that either HIF-1␣ deficiency or previous activation of HIF-1␣ may influence kidney injury as a result of effects on myeloid cell function. HIF-2␣ in bone marrow-derived cells does not seem to contribute to susceptibility to renal ischemia/reperfusion injury 108 ; however, endothelial-specific rescue of HIF-2␣ expression (via angiopoietin receptor Tie-2-Cre) in partially HIF-2␣-deficient mice ameliorates renal injury by ischemia/reperfusion. 108 Clearly, HIFs seem to be involved in many aspects of AKI, but the specific role of each HIF-␣ isoform or the key HIF-␣ isoform-specific genes involved in AKI remain to be defined.
CHRONIC KIDNEY DISEASE
Close scrutiny of renal biopsy specimens shows that functional impairment of the kidney is better correlated with the degree of tubulointerstitial damage than with glomerular injury. [113] [114] [115] [116] Fine et al. 116 proposed that chronic ischemic injury resulting from tubulointerstitial injury and loss of peritubular capillaries is the final common pathway to ESRD. Hypoxia promotes fibrosis by upregulating extracellular matrix production and suppressing turnover of collagen and has been proposed to promote epithelial-tomesenchymal transition, all characteristics of chronic renal disease. HIF induction plays an important mechanistic role in the progression of chronic renal diseases. 117, 118 Studies in the remnant kidney model, a classic model of progressive renal disease, uncovered that tubular hypoxia, stabilization of HIF-1␣, and induction of hypoxia-responsive genes were observed before any observed histologic evidence of tubulointerstitial damage. 119 Tissue-specific ablation of HIF-1␣ in mice using Cre-loxP-mediated gene targeting has been shown to inhibit the development of tubulointerstitial disease, interstitial collagen deposition, epithelial-to-mesenchymal transition, and inflammation in response to unilateral ureteral obstruction. 120 Tubulointerstitial fibrosis appears approximately 4 d after ureteral ligation, whereas tissue hypoxia (as detected by pimonidazole hydrochloride, which forms protein adducts at an oxygen tension of approximately 8 mmHg), is evident in as early as 24 h and persists throughout the development of fibrosis. Concomitantly, both HIF-1␣ and HIF-2␣ are also detected as early as 1 d after ureteral ligation. In this study, the profibrotic effect of HIF-1␣ was partially attributed to the HIF targets lysyl oxidases (Lox and LoxL2 genes) because pharmacologic blockade of these enzymes ameliorated fibrosis in vivo and hypoxia-induced cell migration in vitro.
HIFs are also involved in other renal diseases. Polycystic kidney disease is another important cause of CKD for which HIFs have been recently implicated. Renal cysts are thought to be a premalignant lesion in VHL-deficient clear cell renal cancer where constitutive HIF activation occurs as a result of loss of function of VHL (see above for role of VHL in HIF regulation), suggesting a link between HIF and cystic disease. In support of this notion, mice with conditional knockout of VHL in proximal tubular epithelial cells developed macroscopic and microscopic renal cysts. 121 Surprisingly, conditional deficiency of VHL and HIF-1␤ but not HIF-1␣ suppressed cyst formation, suggesting involvement of HIF-2␣ in cystogenesis. Immunohistochemical analysis of kidneys with autosomal dominant polycystic disease reveal HIF-1␣ expression in cystic epithelial cells and some infiltrating leukocytes, whereas HIF-2␣ expression is limited to vascular endothelial cells, pericystic interstitial cells, and neutrophils. The absence of derangements of oxygen-dependent regulation of HIFs in polycystin-deficient cells excludes a direct influence of polycystin deficiency on aberrant HIF-␣ stabilization. Regardless, HIF accumulation in human and rat polycystic kidney disease is likely responsible for increased EPO production and pericystic hypervascularity and may have an impact on progression of polycystic disease.
The contrasting role of HIFs in acute and chronic renal injuries suggests that the context, cell type, and/or duration of HIF expression determines its effect on disease outcome. Furthermore, the specific roles of HIF-1␣ and HIF-2␣ and their respective downstream targets in chronic renal disease are unclear. 36, 42, 86 For instance, although HIF-2␣ is detected in obstructed kidneys, expression of EPO transcripts is not observed. VEGF is decreased in tubulointerstitial tissue from patients with diabetic nephropathy, whereas other HIF genes are upregulated. It is clear that multiple physiologic and pathologic cues other than hypoxia can lead to HIF activation (e.g., exposure to extracellular acidosis or certain drugs). 18,122-124
CONCLUSIONS
The oxygen-dependent regulation of HIF activity involves very complex pathways that involve prolyl hydroxylases and the VHL tumor suppressor protein, both of which are highly modulated by environmental and physiologic cues (Figure 2) . 17,125 HIF and one of its many downstream target genes, such as VEGF, play fundamental roles in many pathologic as well as physiologic processes that affect the kidney (Figure 3) . The exact roles of the different HIF-␣ isoforms in these processes are still under intense investigation. A number of recent studies using models of renal and nonrenal ischemic injury pointed to a potential protective role for HIFs in these diseases; however, detrimental effects observed when HIF-␣ is dysregulated in cancer suggest a cautionary approach in transitioning to therapeutic strategies from these studies. 41, 126, 127 This is particularly important because our understanding of how HIF-␣ activation can affect cardiovascular physiology, tissue fibrosis, and cancer pathogenesis is still incomplete. 52, 112, 120, 127 The next decade of research is certain to uncover specific pathways delineating the role of hypoxia and HIF in kidney disease and development. The future holds much promise in terms of targeted therapies aimed at these pathways. ACKNOWLEDGMENTS L.G. is funded by a KRESCENT fellowship from Canada. J.V.B. is supported by National Institutes of Health grants DK39773, DK072381, DK074099, and DK054741.
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